CHA University

πŸ‡°πŸ‡·South Korea
Ownership
Private
Established
1999-01-01
Employees
-
Market Cap
-
Website
http://www.cha.ac.kr

Investigation of Predictive Biomarkers in Patients With Advanced BTC Treated With Lenvatinib Plus Pembrolizumab

First Posted Date
2024-10-18
Last Posted Date
2024-10-18
Lead Sponsor
CHA University
Target Recruit Count
100
Registration Number
NCT06648057
Locations
πŸ‡°πŸ‡·

Bundang CHA Medical Center, Seongnam-si, Gyeonggi-do, Korea, Republic of

RCVR (Residual CardioVascular Risk) Prospective Multicenter Study

First Posted Date
2024-09-30
Last Posted Date
2024-09-30
Lead Sponsor
CHA University
Target Recruit Count
1000
Registration Number
NCT06619353
Locations
πŸ‡°πŸ‡·

CHA Bundang Medical Center, Seongnam-si, Gyeonggi-do, Korea, Republic of

MACT (Mono Antiplatelet and Colchicine Therapy) Prospective Multicenter Study

Phase 4
Recruiting
Conditions
Interventions
First Posted Date
2024-08-07
Last Posted Date
2024-08-09
Lead Sponsor
CHA University
Target Recruit Count
490
Registration Number
NCT06543082
Locations
πŸ‡°πŸ‡·

CHA Bundang Medical Center, Seongnam-si, Gyeonggi-do, Korea, Republic of

Comparison of Efficacy and Ocular Surface Assessment Between BRIDIN-plus and Combigan in Glaucoma or Ocular Hypertensive

First Posted Date
2023-10-12
Last Posted Date
2023-10-12
Lead Sponsor
CHA University
Target Recruit Count
60
Registration Number
NCT06078592
Locations
πŸ‡°πŸ‡·

Seungsoo Rho, Seoul, Seongnam, Bundang-gu, Korea, Republic of

Efficacy of Nicotinamide on Retinal Ganglion Cell Functions in Glaucoma Patients

Not Applicable
Recruiting
Conditions
Interventions
First Posted Date
2023-10-12
Last Posted Date
2023-10-12
Lead Sponsor
CHA University
Target Recruit Count
80
Registration Number
NCT06078605
Locations
πŸ‡°πŸ‡·

CHA University Bundang Medical Center, Seongnam, Bundang-gu, Korea, Republic of

Treatment Efficacy of Mindfulness-based Cognitive Therapy for Distress in Advanced Cancer Patients

First Posted Date
2023-03-14
Last Posted Date
2023-04-05
Lead Sponsor
CHA University
Target Recruit Count
40
Registration Number
NCT05768256
Locations
πŸ‡°πŸ‡·

CHA Bundang Medical Center, Seongnam-si, Kyeonggi-do, Korea, Republic of

Clinical Feasibility of Nab-paclitaxel Plus Gemcitabine-cisplatin Chemotherapy in Locally Advanced Cholangiocarcinoma

First Posted Date
2023-01-10
Last Posted Date
2024-02-07
Lead Sponsor
CHA University
Target Recruit Count
100
Registration Number
NCT05677217
Locations
πŸ‡°πŸ‡·

CHA Bundang Medical Center, Seongnam-si, Gyeonggi-do, Korea, Republic of

ROMIAE (Rule-Out Acute Myocardial Infarction Using Artificial Intelligence Electrocardiogram Analysis) Trial

First Posted Date
2022-06-28
Last Posted Date
2022-06-28
Lead Sponsor
CHA University
Target Recruit Count
8814
Registration Number
NCT05435391
Locations
πŸ‡°πŸ‡·

CHA Bundang Medical Center, Seongnam, Korea, Republic of

Therapeutic Effect of Surgical Debulking of Metastatic Lymph Nodes in Cervical Cancer Stage IIICr

First Posted Date
2022-06-16
Last Posted Date
2023-02-09
Lead Sponsor
CHA University
Target Recruit Count
234
Registration Number
NCT05421650
Locations
πŸ‡°πŸ‡·

Gachon University Gil Medical Center, Incheon, Korea, Republic of

πŸ‡°πŸ‡·

Severance Hospital, Seoul, Korea, Republic of

πŸ‡°πŸ‡·

Seoul ST. Mary's Hospital, Seoul, Korea, Republic of

and more 11 locations
Β© Copyright 2024. All Rights Reserved by MedPath